Genetic Risk Assessment for Prostate Cancer - Germline Genetic Testing for Prostate Cancer (BRCA1/2, HOXB13)
An advanced laboratory test screening for genetic mutations like BRCA1, BRCA2, and HOXB13 linked to aggressive prostate cancer. It assesses hereditary risks to guide personalized early detection programs for men.